$CLIR
ClearSign Technologies Corp

2023 Q2 Form 10-Q Financial Statement

#000155837023009840 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $150.0K $894.0K $0.00
YoY Change -100.0%
Cost Of Revenue $21.00K $788.0K $0.00
YoY Change -100.0%
Gross Profit $129.0K $106.0K $0.00
YoY Change -100.0%
Gross Profit Margin 86.0% 11.86%
Selling, General & Admin $1.571M $1.650M $1.409M
YoY Change 6.73% 17.1% 5.94%
% of Gross Profit 1217.83% 1556.6%
Research & Development $187.0K $160.0K $108.0K
YoY Change -0.53% 48.15% -86.92%
% of Gross Profit 144.96% 150.94%
Depreciation & Amortization $78.00K $40.00K $36.00K
YoY Change 116.67% 11.11% -21.74%
% of Gross Profit 60.47% 37.74%
Operating Expenses $1.758M $1.810M $1.517M
YoY Change 5.9% 19.31% -29.74%
Operating Profit -$1.629M -$1.704M -$1.517M
YoY Change -1.87% 12.33% -24.94%
Interest Expense $94.00K $58.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net $151.0K $275.0K $4.000K
YoY Change 586.36% 6775.0%
Pretax Income -$1.478M -$1.429M -$1.490M
YoY Change -9.77% -4.09% -26.24%
Income Tax
% Of Pretax Income
Net Earnings -$1.478M -$1.429M -$1.490M
YoY Change -9.77% -4.09% -26.27%
Net Earnings / Revenue -985.33% -159.84%
Basic Earnings Per Share -$0.04 -$0.04 -$0.05
Diluted Earnings Per Share -$0.04 -$0.04 -$0.05
COMMON SHARES
Basic Shares Outstanding 38.55M 38.54M 31.83M
Diluted Shares Outstanding 38.55M 38.26M 31.83M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.531M $8.489M $6.667M
YoY Change -5.28% 27.33% -37.87%
Cash & Equivalents $7.600M $5.328M $6.667M
Short-Term Investments $931.0K $3.161M
Other Short-Term Assets $575.0K $317.0K $401.0K
YoY Change -4.96% -20.95% -30.86%
Inventory
Prepaid Expenses
Receivables $39.00K $50.00K $27.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.148M $8.860M $7.339M
YoY Change -9.41% 20.72% -35.79%
LONG-TERM ASSETS
Property, Plant & Equipment $478.0K $515.0K $493.0K
YoY Change 0.21% 4.46% -35.13%
Goodwill
YoY Change
Intangibles $762.0K $782.0K $802.0K
YoY Change -6.16% -2.49%
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $1.250M $1.307M $1.305M
YoY Change -3.77% 0.15% -36.65%
TOTAL ASSETS
Total Short-Term Assets $9.148M $8.860M $7.339M
Total Long-Term Assets $1.250M $1.307M $1.305M
Total Assets $10.40M $10.17M $8.644M
YoY Change -8.77% 17.62% -35.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $428.0K $398.0K $294.0K
YoY Change 20.22% 35.37% -33.18%
Accrued Expenses $413.0K $253.0K $196.0K
YoY Change 44.91% 29.08% -48.42%
Deferred Revenue $2.105M $639.0K $84.00K
YoY Change 2405.95% 660.71%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.041M $1.367M $786.0K
YoY Change 219.43% 73.92% -9.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $199.0K $213.0K $294.0K
YoY Change -21.03% -27.55% -42.35%
Total Long-Term Liabilities $199.0K $213.0K $294.0K
YoY Change -21.03% -27.55% -61.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.041M $1.367M $786.0K
Total Long-Term Liabilities $199.0K $213.0K $294.0K
Total Liabilities $3.240M $1.580M $1.080M
YoY Change 169.1% 46.3% -33.74%
SHAREHOLDERS EQUITY
Retained Earnings -$91.43M -$90.00M -$84.30M
YoY Change 6.44% 6.76%
Common Stock $4.000K $4.000K $3.000K
YoY Change 0.0% 33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.158M $8.587M $7.564M
YoY Change
Total Liabilities & Shareholders Equity $10.40M $10.17M $8.644M
YoY Change -8.77% 17.62% -35.92%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.478M -$1.429M -$1.490M
YoY Change -9.77% -4.09% -26.27%
Depreciation, Depletion And Amortization $78.00K $40.00K $36.00K
YoY Change 116.67% 11.11% -21.74%
Cash From Operating Activities $46.00K -$554.0K -$1.503M
YoY Change -102.49% -63.14% -0.66%
INVESTING ACTIVITIES
Capital Expenditures $32.00K $24.00K $5.000K
YoY Change -180.0% 380.0% -90.74%
Acquisitions
YoY Change
Other Investing Activities $2.270M -$530.0K $23.00K
YoY Change 16114.29% -2404.35%
Cash From Investing Activities $2.238M -$554.0K -$15.00K
YoY Change -8707.69% 3593.33% -82.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -15.00K 578.0K
YoY Change -100.0% -102.6% -83.5%
NET CHANGE
Cash From Operating Activities 46.00K -554.0K -1.503M
Cash From Investing Activities 2.238M -554.0K -15.00K
Cash From Financing Activities 0.000 -15.00K 578.0K
Net Change In Cash 2.284M -1.123M -940.0K
YoY Change -2.81% 19.47% -149.45%
FREE CASH FLOW
Cash From Operating Activities $46.00K -$554.0K -$1.503M
Capital Expenditures $32.00K $24.00K $5.000K
Free Cash Flow $14.00K -$578.0K -$1.508M
YoY Change -100.78% -61.67% -3.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001434524
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38545556
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38023701
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35521
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CLEARSIGN TECHNOLOGIES CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2056298
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8023 E. 63rd Place, Suite 101
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74133
CY2023Q1 dei City Area Code
CityAreaCode
918
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
236-6461
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
CLIR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38545556
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5328000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6451000
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
3161000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2606000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
79000
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
20000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
317000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
577000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
8860000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
9733000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
515000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
782000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1517000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
58000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
798000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2023Q1 us-gaap Assets
Assets
10167000
CY2022Q4 us-gaap Assets
Assets
10925000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
398000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
296000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
133000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
253000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
471000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
639000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
247000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1367000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1147000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
213000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
226000
CY2023Q1 us-gaap Liabilities
Liabilities
1580000
CY2022Q4 us-gaap Liabilities
Liabilities
1373000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38545556
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38023701
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98543000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98079000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89952000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88523000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8587000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9552000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10167000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10925000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
894000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
788000
CY2023Q1 us-gaap Gross Profit
GrossProfit
106000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
160000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1650000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1409000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1810000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1517000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1704000
CY2023Q1 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
93000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
23000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
119000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
275000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1429000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1490000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38262710
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38262710
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31826221
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31826221
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9552000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
227000
CY2023Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
234000
CY2023Q1 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
0.66
CY2023Q1 clir Stock Issued During Period Value Issued For Services Four
StockIssuedDuringPeriodValueIssuedForServicesFour
3000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1429000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8587000
CY2022Q1 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2022Q1 clir Common Stock Issued For Exercise Of Options2.93 Per Share
CommonStockIssuedForExerciseOfOptions2.93PerShare
2.93
CY2022Q1 clir Share Issued For At Market Issuance1.24 Per Share
ShareIssuedForAtMarketIssuance1.24PerShare
1.24
CY2022Q1 clir Common Stock For Services Per Share Issue Two
CommonStockForServicesPerShareIssueTwo
1.93
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1429000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1490000
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3000
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
242000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
80000
CY2023Q1 clir Depreciation And Amortization Excluding Right Of Use Asset Amortization
DepreciationAndAmortizationExcludingRightOfUseAssetAmortization
80000
CY2022Q1 clir Depreciation And Amortization Excluding Right Of Use Asset Amortization
DepreciationAndAmortizationExcludingRightOfUseAssetAmortization
36000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
23000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
43000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
35000
CY2023Q1 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
20000
CY2023Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
14000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-16000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
205000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-51000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
56000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
57000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
22000
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1000
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
85000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
392000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-554000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1503000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24000
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
33000
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5000
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
23000
CY2023Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
2162000
CY2023Q1 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
1627000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-554000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
578000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
578000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1123000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-940000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6451000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7607000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5328000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6667000
CY2023Q1 clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
234000
CY2022Q1 clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
107000
CY2023Q1 clir Prior Year Prepaid Expenses Repurposed To Fixed Assets As Demonstration Equipment
PriorYearPrepaidExpensesRepurposedToFixedAssetsAsDemonstrationEquipment
209000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5328000
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
3161000
CY2023Q1 clir Gross Proceeds From Issuance Of Common Stock Under Program To Date
GrossProceedsFromIssuanceOfCommonStockUnderProgramToDate
91000000.0
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90000000.0
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
3161000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2606000
CY2023Q1 clir Unrealized Holding Gain Loss On Short Term Investments
UnrealizedHoldingGainLossOnShortTermInvestments
33000
CY2022Q4 clir Unrealized Holding Gain Loss On Short Term Investments
UnrealizedHoldingGainLossOnShortTermInvestments
4000
CY2023Q1 us-gaap Debt Securities Held To Maturity Fair Value Current
DebtSecuritiesHeldToMaturityFairValueCurrent
3194000
CY2022Q4 us-gaap Debt Securities Held To Maturity Fair Value Current
DebtSecuritiesHeldToMaturityFairValueCurrent
2610000
CY2022Q1 us-gaap Research And Development Arrangement With Federal Government Customer Funding To Offset Costs Incurred
ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
0
CY2023Q1 us-gaap Research And Development Arrangement With Federal Government Customer Funding To Offset Costs Incurred
ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
0
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3700000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3300000
CY2023Q1 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
312000
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
759000
CY2023Q1 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
81000
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
697000
CY2023Q1 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
231000
CY2022Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
62000
CY2023Q1 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
284000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
322000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
515000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384000
CY2023Q1 us-gaap Depreciation
Depreciation
40000
CY2022Q1 us-gaap Depreciation
Depreciation
7000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-9000
CY2023Q1 clir Operating Leases Monthly Rent Expense
OperatingLeasesMonthlyRentExpense
11000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
48000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
57000
CY2023Q1 clir Lessee Operating Lease Liability Discounted Payments Due Year Four
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearFour
50000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
51000
CY2023Q1 clir Lessee Operating Lease Liability Discounted Payments Due
LesseeOperatingLeaseLiabilityDiscountedPaymentsDue
290000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
322000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
32000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
284000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
322000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
133000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
213000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
226000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
290000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
359000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2023Q1 us-gaap Payments For Rent
PaymentsForRent
66000
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
57000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-9000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5000
CY2023Q1 clir Lessee Operating Lease Liability Discounted Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityDiscountedPaymentsRemainderOfFiscalYear
64000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
73000
CY2023Q1 clir Lessee Operating Lease Liability Discounted Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths
54000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
65000
CY2023Q1 clir Lessee Operating Lease Liability Discounted Payments Due Year Two
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearTwo
59000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
66000
CY2023Q1 clir Lessee Operating Lease Liability Discounted Payments Due Year Three
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearThree
63000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
67000
CY2023Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1145000
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1122000
CY2023Q1 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
102000
CY2022Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
101000
CY2023Q1 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2022Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1255000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1231000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
473000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
433000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
782000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
798000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
108000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
126000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
96000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
61000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
39000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
7000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
437000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
894000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
788000
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
20000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
639000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
247000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
62500000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000.0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2779000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.05
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M4D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2779000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.05
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M4D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2011000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.70
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M4D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
27000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1000000.0

Files In Submission

Name View Source Status
0001558370-23-009840-index-headers.html Edgar Link pending
0001558370-23-009840-index.html Edgar Link pending
0001558370-23-009840.txt Edgar Link pending
0001558370-23-009840-xbrl.zip Edgar Link pending
clir-20230331.xsd Edgar Link pending
clir-20230331x10q.htm Edgar Link pending
clir-20230331xex31d1.htm Edgar Link pending
clir-20230331xex31d2.htm Edgar Link pending
clir-20230331xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
clir-20230331_cal.xml Edgar Link unprocessable
clir-20230331_def.xml Edgar Link unprocessable
clir-20230331_lab.xml Edgar Link unprocessable
clir-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clir-20230331x10q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending